Volume | 874 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Beam Therapeutics Inc | BEAM | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
21.60 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
19 | 874 | - | 16.95 - 49.50 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
08:00:02 | 1 | $ 22.05 | USD |
Beam Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.76B | 81.66M | - | 377.71M | -132.53M | -1.62 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Beam Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BEAM Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 24.11 | 25.4699 | 20.84 | 23.42 | 2,244,721 | -2.25 | -9.33% |
1 Month | 32.90 | 32.99 | 20.84 | 26.00 | 1,689,365 | -11.04 | -33.56% |
3 Months | 25.46 | 49.50 | 20.84 | 32.22 | 1,539,737 | -3.60 | -14.14% |
6 Months | 19.51 | 49.50 | 18.18 | 28.97 | 1,499,146 | 2.35 | 12.05% |
1 Year | 30.42 | 49.50 | 16.95 | 28.56 | 1,189,751 | -8.56 | -28.14% |
3 Years | 77.00 | 138.5219 | 16.95 | 47.53 | 1,021,225 | -55.14 | -71.61% |
5 Years | 19.19 | 138.5219 | 13.00 | 49.96 | 915,497 | 2.67 | 13.91% |
Beam Therapeutics Description
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. |